In the eye of the storm: managing a genetically engineered mass casualty – Ganesh Suntharalingam
In March 2006, six healthy volunteers underwent cytokine-induced injury and multi-organ failure from a Phase 1 first-in-human drug trial with a novel monoclonal antibody. This talk describes the clinical and incident management ramifications, drawing connections to other non-conventional incidents which may pose a different pattern of clinical, operational and communications challenges to the ‘classic’ trauma-based model of major incidents.
Podcast discussion of incident management in non-conventional, ICU-centred major incidents including the TGN1412 drug trial
Ganesh Suntharalingam has been a consultant intensivist at Northwick Park hospital for 20 years, and is currently President of the Intensive Care Society (UK).He ran the ICS State of the Art conference for 3 years from 2015 – 2017. He has an amateur sideline in healthcare architecture and design and is a regular panel judge at the European Healthcare Design Awards.
For a period of a few days in 2006 he repeatedly appeared on international news bulletins alongside Saddam Hussein and Tony Blair (although for unrelated reasons).He is the only one of these to still be in post.
The Coda Community